Comprehensive mutational profiling of core binding factor acute myeloid leukemia N Duployez, A Marceau-Renaut, N Boissel, A Petit, M Bucci, S Geffroy, ... Blood 127 (20), 2451-2459, 2016 | 260 | 2016 |
Frequent ASXL2 mutations in acute myeloid leukemia patients with t (8;21)/RUNX1-RUNX1T1 chromosomal translocations JB Micol, N Duployez, N Boissel, A Petit, S Geffroy, O Nibourel, ... Blood 124 (9), 1445, 2014 | 139 | 2014 |
Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia I Antony-Debré, N Duployez, M Bucci, S Geffroy, JB Micol, A Renneville, ... Leukemia 30 (4), 999-1002, 2016 | 112 | 2016 |
Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience A Diarra, N Duployez, E Fournier, C Preudhomme, V Coiteux, L Magro, ... Blood Advances 6 (3), 998-1003, 2022 | 109 | 2022 |
Acute myeloid leukemia: the good, the bad, and the ugly A Kuykendall, N Duployez, N Boissel, JE Lancet, JS Welch American Society of Clinical Oncology Educational Book 38, 555-573, 2018 | 109 | 2018 |
Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements I Tanasi, I Ba, N Sirvent, T Braun, W Cuccuini, P Ballerini, N Duployez, ... Blood, The Journal of the American Society of Hematology 134 (16), 1351-1355, 2019 | 105 | 2019 |
Mutational profile and benefit of gemtuzumab ozogamicin in acute myeloid leukemia E Fournier, N Duployez, B Ducourneau, E Raffoux, P Turlure, D Caillot, ... Blood, The Journal of the American Society of Hematology 135 (8), 542-546, 2020 | 71 | 2020 |
Mutant UBA1 and severe adult-onset autoinflammatory disease. L Luzzatto, AM Risitano, R Notaro The New England journal of medicine 384 (22), 2164-2164, 2021 | 68 | 2021 |
Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results C Gardin, C Pautas, E Fournier, R Itzykson, E Lemasle, JH Bourhis, ... Blood advances 4 (9), 1942-1949, 2020 | 65 | 2020 |
ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia JB Micol, A Pastore, D Inoue, N Duployez, E Kim, SCW Lee, BH Durham, ... Nature communications 8 (1), 15429, 2017 | 61 | 2017 |
CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia J Schmoellerl, IAM Barbosa, T Eder, T Brandstoetter, L Schmidt, B Maurer, ... Blood, The Journal of the American Society of Hematology 136 (4), 387-400, 2020 | 60 | 2020 |
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study N Duployez, L Largeaud, M Duchmann, R Kim, J Rieunier, J Lambert, ... Blood, The Journal of the American Society of Hematology 140 (7), 756-768, 2022 | 55 | 2022 |
Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemia R Itzykson, N Duployez, A Fasan, G Decool, A Marceau-Renaut, ... Blood, The Journal of the American Society of Hematology 132 (2), 187-196, 2018 | 55 | 2018 |
Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemia R Itzykson, N Duployez, A Fasan, G Decool, A Marceau-Renaut, ... Blood, The Journal of the American Society of Hematology 132 (2), 187-196, 2018 | 55 | 2018 |
13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking M Yang, S Safavi, EL Woodward, N Duployez, L Olsson-Arvidsson, ... Blood, The Journal of the American Society of Hematology 136 (8), 946-956, 2020 | 53 | 2020 |
Molecular profiling defines distinct prognostic subgroups in childhood AML: a report from the French ELAM02 study group A Marceau-Renaut, N Duployez, B Ducourneau, M Labopin, A Petit, ... HemaSphere 2 (1), e31, 2018 | 53 | 2018 |
Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias V Lestringant, N Duployez, D Penther, I Luquet, C Derrieux, A Lutun, ... Genes, Chromosomes and Cancer 60 (10), 657-667, 2021 | 50 | 2021 |
The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia N Duployez, A Marceau-Renaut, C Villenet, A Petit, A Rousseau, SWK Ng, ... Leukemia 33 (2), 348-357, 2019 | 49 | 2019 |
Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy R Itzykson, E Fournier, C Berthon, C Röllig, T Braun, A Marceau-Renaut, ... Blood, The Journal of the American Society of Hematology 138 (7), 507-519, 2021 | 45 | 2021 |
NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors N Duployez, G Grzych, B Ducourneau, MA Fuentes, N Grardel, T Boyer, ... Haematologica 101 (4), e133, 2016 | 44 | 2016 |